A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis

Ana Cuadrado, Vanesa Lafarga, Peter C.F. Cheung, Ignacio Dolado, Susana Llanos, Philip Cohen, Angel R. Nebreda

    Research output: Contribution to journalArticlepeer-review

    73 Citations (Scopus)


    The p38 mitogen-activated protein kinase (MAPK) signaling pathway plays an important role in stress-induced cell-fate decisions by orchestrating responses that go from cell-cycle arrest to apoptosis. We have identified a new p38 MAPK-regulated protein that we named p18Hamlet, which becomes stabilized and accumulates in response to certain genotoxic stresses such as UV or cisplatin treatment. Overexpression of p18Hamlet is sufficient to induce apoptosis, whereas its downregulation reduces the apoptotic response to these DNA damage-inducing agents. We show that p18Hamlet interacts with p53 and stimulates the transcription of several proapoptotic p53 target genes such as PUMA and NOXA. This correlates with enhanced p18 Hamlet-induced recruitment of p53 to the promoters. In proliferating cells, low steady-state levels of p18Hamlet are probably maintained by a p53-dependent negative feedback loop. Therefore, p18Hamlet is a new cell-fate regulator that links the p38 MAPK and p53 pathways and contributes to the establishment of p53-regulated stress responses.

    Original languageEnglish
    Pages (from-to)2115-2126
    Number of pages12
    JournalEMBO Journal
    Issue number8
    Publication statusPublished - 18 Apr 2007


    • Apoptosis
    • p38 MAP kinase
    • p53
    • Stress response
    • Transcriptional coactivator

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Molecular Biology
    • Biochemistry, Genetics and Molecular Biology(all)
    • Immunology and Microbiology(all)


    Dive into the research topics of 'A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis'. Together they form a unique fingerprint.

    Cite this